最新ニュース 2seventy bio (NASDAQ:TSVT) 株価情報

2seventy bio

2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.

2seventy bio Inc

Luxury sports car manufacturer Porsche AG is implementing major organizational <a target="_blank" href="https://newsroom.porsche.com/en/2025/company/porsche-annual-press-conference-financial-year-2024-annual-and-sustainability-report-38687.html" rel="noreferrer noopener">changes </a>to boost efficiency and secure long-term financial success.
The company has introduced an extensive restructuring initiative aimed at cutting approximately 1,900 positions by 2029.
This reduction will be achieved through natural employee turnover, demographic shifts, and a stringent hiring approach.
The company will also offer social measures, including voluntary partial retirement options and severance agreements. Additionally, 2,000 roles will be eliminated as fixed-term contracts expire, with further restructuring efforts anticipated later in the year.
As part of this restructuring, Jochen Breckner has assumed leadership of Finance and IT, while Matthias Becker took over Sales and Marketing in February, following the mutual departures of Lutz Meschke and Detlev von Platen from their positions at the company.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/25/03/44245996/why-is-southwest-airlines-stock-rising-today" rel="noreferrer noopener">Southwest Airlines Introduces Paid Baggage system; Cuts Guidance</a>
In 2025, Porsche&nbsp;expects to intensify the Road to 20 performance program, particularly focusing on cost reduction to improve profitability.
The program's goal is to reach an operating return on sales of over 20 percent. Starting in 2025, Porsche AG intends to allocate an extra 800 million euros (~$873.69 million) to enhance its product portfolio, as well as software and battery development.
However, these investments are expected to have a negative impact on the company's financial performance for this year. The company highlighted ongoing geopolitical uncertainties and increased competition, particularly in China, as key factors affecting the 2025 outlook.
&#8220;We are consciously setting out on a comprehensive recalibration and sustainably strengthening Porsche for the future,&#8221; said Breckner.
The company anticipates an operating return of 10% &#8211; 12% in 2025, lower than the 2024 results, primarily due to reduced vehicle sales and elevated costs.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/03/44246040/kohls-anticipates-sales-and-profit-dip-in-2025-slashes-dividend-by-75-stock-tanks" target="_blank" rel="noreferrer noopener">Kohl&#8217;s Anticipates Sales And Profit Dip In 2025, Slashes Dividend By 75%</a></li>
</ul>
Photo by Maqqerso on Shutterstock.

Equities

News

General

DR ING H C F PRSCHE U/ADR by DR ING H C F PORSCHE AG

DRPRY

Porsche AG To Cut 3,900 Jobs, Warns Of Challenging Market Conditions

Salesforce Inc.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>) has committed&nbsp;to invest $1 billion in&nbsp;the country&#8217;s AI sector&nbsp;over the next five years.&nbsp;The investment is aimed at promoting the adoption of Salesforce&#8217;s AI product, Agentforce.
What Happened: Salesforce, on Tuesday, unveiled its plans to inject $1 billion into Singapore&#8217;s AI industry over the next half-decade. The initiative aims to speed up the country&#8217;s digital transformation and promote the adoption of Agentforce, Salesforce&#8217;s leading AI solution.
Having operated in Singapore for around 25 years, Salesforce believes this investment will bolster Singapore&#8217;s workforce in various&nbsp;key service and public sector&nbsp;roles. This comes at a critical moment as the country faces challenges from an aging population and declining birth rates.
Salesforce&#8217;s AI Research hub in Singapore has driven product innovations, including AIOps Agents that enhance Salesforce&#8217;s site availability and in-house code LLMs that assist customers in optimizing their code for better performance. Their work has led to the publication of over 100 research papers and patents.
Salesforce is enhancing its services on Hyperforce in Singapore to offer data residency for Data Cloud, Agentforce, and Unified Marketing Applications (UMA) by next month. This will enable Singapore businesses to leverage Salesforce's Agentforce and data solutions while complying with local data residency regulations.
SEE ALSO:<a href="https://www.benzinga.com/news/25/03/44211103/jim-cramer-asks-do-we-just-keep-selling-because-everyone-is-selling-calls-it-the-every-day-lower-prices-walmart-white-house"> Jim Cramer Asks, &#8216;Do We Just Keep Selling Because Everyone Is Selling?&#8217;—Calls It The &#8216;Every Day Lower Prices Walmart White House&#8217;</a>
Why It Matters: This investment comes on the heels of Salesforce&#8217;s recent unveiling of Agentforce 2dx at the TrailblazerDX conference. The new product represents a significant advancement from reactive to proactive agentic capabilities in the AI sector. Notably, today Salesforce also <a href="https://www.benzinga.com/news/contracts/25/03/44272237/ai-takes-flight-singapore-airlines-taps-salesforce-for-next-gen-customer-service-tech">announced a collaboration</a> with Singapore Airlines (SIA) to enhance the customer case management system.
Goldman Sachs analyst <a href="https://www.benzinga.com/25/03/44200350/salesforce-ai-expansion-sparks-analyst-optimism-400-price-forecast-set">Kash Rangan expressed</a> optimism about Salesforce&#8217;s execution of its AI product roadmap, setting a price target of $400 for the company&#8217;s stock. This investment in Singapore&#8217;s AI sector is likely to further strengthen Salesforce&#8217;s position in the global AI market.
CRM stock surged 9.35% over the past six months to close at $277.05 on Tuesday as per <a href="https://pro.benzinga.com/dashboard">BenzingaPro</a>.
<ul>
<li>READ MORE: <a href="https://www.benzinga.com/markets/equities/25/03/44271204/tsmc-proposes-joint-venture-with-nvidia-amd-and-broadcom-to-operate-intels-factories-report">TSMC Proposes Joint Venture With Nvidia, AMD And Broadcom To Operate Intel&#8217;s Factories: Report</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Markets

Tech

Salesforce Doubles Down On AI With $1 Billion Investment In Singapore Over Next 5 Years

Stifel analyst Daniel Arias maintains MaxCyte (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MXCT#NASDAQ">MXCT</a>) with a Buy and lowers the price target from $11 to $9.

Price Target

Analyst Ratings

MXCT

Stifel Maintains Buy on MaxCyte, Lowers Price Target to $9

Crypto asset manager Bitwise Asset Management, overseeing $12 billion in client assets, has announced the launched the Bitwise Bitcoin Standard Corporations ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OWNB#NYSE">OWNB</a>) on NYSE Arca, targeting companies holding at least 1,000 Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) in their corporate treasuries. 
What Happened: <a href="https://www.businesswire.com/news/home/20250311165166/en/The-Bitwise-Bitcoin-Standard-Corporations-ETF-Ticker-OWNB-Launches-on-NYSE-Arca-Tracks-Publicly-Traded-Companies-That-Own-at-Least-1000-BTC">Announced</a> on March 11, the ETF tracks the Bitwise Bitcoin Standard Corporations Index, spotlighting over 70 publicly traded firms that have embraced Bitcoin as a treasury asset, reflecting a growing corporate trend to diversify cash reserves amid economic uncertainty.
The ETF's structure emphasizes companies with significant Bitcoin holdings, with the index weighting firms based on the amount of Bitcoin they own, though the largest holding—Strategy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>)—is capped at 20% to ensure diversification. 
Other top holdings include MARA Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>), CleanSpark (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLSK#NASDAQ">CLSK</a>), Riot Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIOT#NASDAQ">RIOT</a>), Boyaa Interactive, Metaplanet (TYO:<a class="ticker" href="https://www.benzinga.com/stock/TYO:3350#TYO">3350</a>), Aker ASA, Bitfarms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BITF#NASDAQ">BITF</a>), BitFuFu (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FUFU#NASDAQ">FUFU</a>) and Galaxy Digital (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BRPHF#OTC">BRPHF</a>).
Bitwise noted that corporations with Bitcoin holdings exceeding 1,000 BTC but constituting less than one-third of their balance sheet are assigned a 1.5% weighting. 
The index rebalances quarterly, with changes announced in advance to maintain transparency.
Bitwise highlighted the motivations behind this corporate shift, pointing to the Federal Reserve's data showing U.S. nonfinancial corporations held over $4.5 trillion in cash and deposits as of Q3 2024. 
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44264824/can-donald-trump-end-the-war-in-ukraine-polymarket-traders-say-the-odds-are-rising-but-one-question-is-key">Can Donald Trump End The War In Ukraine? Polymarket Traders Say The Odds Are Rising, But One Question Is Key</a>
"According to the Federal Reserve, companies are sitting on $5 trillion in low-yielding cash today, and many are recognizing Bitcoin's value as a strategic reserve asset," Bitwise <a href="https://x.com/BitwiseInvest/status/1899445386038620631">stated</a> in their X post, suggesting firms view Bitcoin as a hedge against monetary policy risks, such as the U.S. government's $2 trillion annual deficit.
The ETF does not invest directly in Bitcoin or through derivatives, instead offering investors exposure to the financial performance of these Bitcoin-holding companies. 
"Individuals have understood the Bitcoin standard for years. Now, more and more corporations do, too," Bitwise emphasized in their announcement, underscoring the growing acceptance of Bitcoin as a corporate asset. 
What&#8217;s Next: Bitwise CIO Matt Hougan further elaborated on the rationale, stating in a related press release, "Companies perceive Bitcoin as a strategic reserve asset that's liquid and scarce—and not subject to the whims or money printing of any government."
The launch follows Bitwise's filing with the SEC in December 2024, reflecting a broader trend of corporate Bitcoin adoption, with firms like Strategy leading the charge by holding 499,096 BTC, valued at over $41 billion. 
The ETF, distributed by Foreside Fund Services, LLC, aims to provide a regulated investment vehicle for those seeking indirect exposure to Bitcoin's market dynamics through corporate equity.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44258476/bitcoin-reserve-upgrades-crypto-but-paypal-ripple-stablecoins-lag-behind">Bitcoin Reserve Upgrades Crypto But Paypal, Ripple Stablecoins Lag Behind</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

BITF

BRPHF

CLSK

FUFU

MSTR

Bitwise Funds Trust Bitwise Bitcoin Standard Corporations ETF

OWNB

RIOT

TYO:3350

Bitwise Launches ETF Tracking Firms With Over 1,000 Bitcoin

PWNX

CORRECTION: Prestige Wealth Ticker Is 'PWM'

Prestige Wealth InnoSphere Tech Subsidiary Integrates DeepSeek

Guidance

ABM Indus Raised The Lower End Of Its FY25 Adjusted EPS Outlook By $0.05, Now Expecting Adjusted EPS To Range From $3.65 To $3.80 Vs. Cons. Of $3.73

WIIM

OPRX

OptimizeRx shares are trading higher after the company reported better-than-expected Q4 earnings and sales.

TRNR

Interactive Strength shares are trading higher after the company secured $3.6 million in 3-year notes from an institutional investor, following a $2.9 million investment.

Stifel analyst Brian Brophy maintains Limbach Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMB#NASDAQ">LMB</a>) with a Buy and raises the price target from $102 to $103.

Stifel Maintains Buy on Limbach Holdings, Raises Price Target to $103

Telsey Advisory Group analyst Dana Telsey maintains Kohl's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KSS#NYSE">KSS</a>) with a Market Perform and lowers the price target from $13 to $10.

Telsey Advisory Group Maintains Market Perform on Kohl's, Lowers Price Target to $10

Stifel analyst Jim Duffy maintains Dick's Sporting Goods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DKS#NYSE">DKS</a>) with a Hold and lowers the price target from $240 to $226.

Stifel Maintains Hold on Dick's Sporting Goods, Lowers Price Target to $226

HC Wainwright &amp; Co. analyst Yi Chen maintains LifeMD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LFMD#NASDAQ">LFMD</a>) with a Buy and raises the price target from $12 to $14.

LFMD

HC Wainwright & Co. Maintains Buy on LifeMD, Raises Price Target to $14

ONDS

Ondas Sees FY25 Revenue Of $25M Vs. $33.44M Est.

Ondas Posts Q4 Net Loss Of $10.3M Versus $14.1M In Q4 FY23

HC Wainwright &amp; Co. analyst Yi Chen maintains Zynex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZYXI#NASDAQ">ZYXI</a>) with a Buy and lowers the price target from $17 to $15.

ZYXI

HC Wainwright & Co. Maintains Buy on Zynex, Lowers Price Target to $15

Ondas Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONDS#NASDAQ">ONDS</a>) reported quarterly sales of $7.19 million which beat the analyst consensus estimate of $5.75 million by 25.08 percent. This is a 44.97 percent increase over sales of $4.96 million the same period last year.

Earnings

Earnings Beats

Ondas Holdings Q4 Sales $7.19M Beat $5.75M Estimate

HC Wainwright &amp; Co. analyst Raghuram Selvaraju reiterates BrainsWay (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BWAY#NASDAQ">BWAY</a>) with a Buy and maintains $16 price target.

Reiteration

BWAY

HC Wainwright & Co. Reiterates Buy on BrainsWay, Maintains $16 Price Target

Telsey Advisory Group analyst Dana Telsey maintains Grove Collaborative Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GROV#NYSE">GROV</a>) with a Outperform and maintains $2 price target.

GROV

Telsey Advisory Group Maintains Outperform on Grove Collaborative Hldgs, Maintains $2 Price Target

Sprinklr Sees FY26 Revenues Between $821.5M-$823.5M Vs. $819.73M Estimate, With Adjusted EPS Of $0.38-$0.39 Vs. $0.38 Estimate

Press Releases

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 2seventy bio, Inc. - TSVT

2seventy bio to Report Third Quarter 2024 Financial Results and Participate in Upcoming Investor Conference

2seventy bio Reports Third Quarter Financial Results and Recent Operational Progress

2seventy bio Reports Preliminary* Full-Year U.S. Abecma Sales and Select Financial Results

2seventy bio to Participate in the 2025 TD Cowen Healthcare Conference

2seventy bio Enters into Definitive Agreement to be Acquired by Bristol Myers Squibb

TSVT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of 2seventy bio, Inc. Is Fair to Shareholders

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of 2seventy bio, Inc.

Shareholder Alert: The Ademi Firm investigates whether 2seventy bio, Inc. is obtaining a Fair Price for its Public Shareholders

Comments

2seventy bio

ニュース

最新ニュース 2seventy bio (NASDAQ:TSVT) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル